Universal-Beteiligungs- und Servicegesellschaft
DNTH icon

Universal-Beteiligungs- und Servicegesellschaft’s Dianthus Therapeutics DNTH Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.45M Buy
41,087
+30,287
+280% +$1.75M 0.01% 1039
2025
Q4 		$445K Sell
10,800
-4,934
-31% -$191K ﹤0.01% 1750
2025
Q3 		$619K Buy
+15,734
New +$402K ﹤0.01% 1701

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's DNTH Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Dianthus Therapeutics (DNTH) stake by 280% in Q1 2026, buying an estimated $1.75M and bringing the position to 41,087 shares worth $3.45M. The position accounts for 0.01% of the portfolio, ranked #1039.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in DNTH in Q3 2025 and has held it in 3 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 41,087 shares of Dianthus Therapeutics worth $3.45M as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 30,287 Dianthus Therapeutics shares in Q1 2026, an estimated $1.75M.
  • Dianthus Therapeutics made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #1039 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Dianthus Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.